CRP and androgen insensitivity syndrome: There was a significant difference in lymphocyte count (1.54 ± 1.5 103/μL vs. 1.66 ± 0.7 103/μl; p = 0.04) and C-reactive protein (CRP) levels (59.4 ± 68.4 mg/L vs. 21.9 ± 40.9 mg/L; p = 0.0012) between COVID-19 and non-COVID-19 AIS patients.